Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors. The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [11/13/2025 13:58 PST] Prelude Therapeutics Incorporated (NASDAQ:PRLD), Up By 100% ($1.31) From $1.31 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [11/12/2025 10:30 PST] Prelude Therapeutics Incorporated (NASDAQ:PRLD), Up By 100% ($1.21) From $1.21 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [11/12/2025 06:53 PST] PRLD Expected to Trade Up After Bullish Patterns Develop
• [11/10/2025 07:39 PST] PRLD Expected to Trade Up After Bullish Patterns Develop
• [11/07/2025 07:09 PST] PRLD Expected to Trade Down After Bearish Patterns Develop
• [11/05/2025 16:30 PST] Prelude Therapeutics Incorporated (NASDAQ:PRLD), Down By 100% ($1.66) From $1.66 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [11/04/2025 21:21 PST] Market Maker Surveillance Report. PRLD, Losing Stocks With Lowest Price Friction For Tuesday, November 4th 2025
• [11/04/2025 06:22 PST] PRLD Expected to Trade Up Short Term
• [11/03/2025 21:21 PST] Market Maker Surveillance Report. PRLD, Winning Stocks With Lowest Price Friction For Monday, November 3rd 2025
• [11/03/2025 16:30 PST] Prelude Therapeutics Incorporated (NASDAQ:PRLD), Up By 100% ($1.66) From $1.66 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/27/2025 06:48 PDT] PRLD Expected to Trade Down After Bearish Patterns Develop
• [10/22/2025 07:23 PDT] PRLD Expected to Trade Up Short Term
• [10/21/2025 21:21 PDT] Market Maker Surveillance Report. PRLD, Winning Stocks With Lowest Price Friction For Tuesday, October 21st 2025
• [10/21/2025 13:20 PDT] Prelude Therapeutics Incorporated (NASDAQ:PRLD), Up By 100% ($1.31) From $1.31 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/17/2025 07:17 PDT] PRLD Expected to Trade Up After Bullish Patterns Develop
• [10/10/2025 11:45 PDT] Prelude Therapeutics Incorporated (NASDAQ:PRLD), Down By 100% ($1.46) From $1.46 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [10/07/2025 07:28 PDT] PRLD Expected to Trade Down After Bearish Patterns Develop